ATE266423T1 - Betablocker enthaltende ophtalmische zusammensetzungen - Google Patents

Betablocker enthaltende ophtalmische zusammensetzungen

Info

Publication number
ATE266423T1
ATE266423T1 AT99909028T AT99909028T ATE266423T1 AT E266423 T1 ATE266423 T1 AT E266423T1 AT 99909028 T AT99909028 T AT 99909028T AT 99909028 T AT99909028 T AT 99909028T AT E266423 T1 ATE266423 T1 AT E266423T1
Authority
AT
Austria
Prior art keywords
ophtalmic
compositions containing
beta blockers
containing beta
composition
Prior art date
Application number
AT99909028T
Other languages
English (en)
Inventor
Florence Maurin
Elisabeth Latour
Claude Coquelet
Original Assignee
Chauvin Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chauvin Lab Sa filed Critical Chauvin Lab Sa
Application granted granted Critical
Publication of ATE266423T1 publication Critical patent/ATE266423T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99909028T 1998-04-09 1999-03-17 Betablocker enthaltende ophtalmische zusammensetzungen ATE266423T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804489A FR2777189B1 (fr) 1998-04-09 1998-04-09 Composition ophtalmique comprenant un beta-bloquant
PCT/FR1999/000612 WO1999052559A1 (fr) 1998-04-09 1999-03-17 COMPOSITION OPHTALMIQUE COMPRENANT UN β-BLOQUANT

Publications (1)

Publication Number Publication Date
ATE266423T1 true ATE266423T1 (de) 2004-05-15

Family

ID=9525090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909028T ATE266423T1 (de) 1998-04-09 1999-03-17 Betablocker enthaltende ophtalmische zusammensetzungen

Country Status (14)

Country Link
US (1) US6399605B1 (de)
EP (1) EP1067966B1 (de)
JP (1) JP3725783B2 (de)
KR (1) KR100397622B1 (de)
CN (1) CN1139403C (de)
AT (1) ATE266423T1 (de)
AU (1) AU2842199A (de)
CA (1) CA2324887C (de)
DE (1) DE69917245T2 (de)
DK (1) DK1067966T3 (de)
ES (1) ES2221740T3 (de)
FR (1) FR2777189B1 (de)
PT (1) PT1067966E (de)
WO (1) WO1999052559A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS137402A0 (en) * 2002-03-26 2002-05-09 Fujisawa Pharmaceutical Co., Ltd. Novel tricyclic compounds
US20060142270A1 (en) * 2004-12-23 2006-06-29 Kowa Co., Ltd. Preventing or treating agent for glaucoma
TWI367098B (en) 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
JP2006298907A (ja) * 2005-03-22 2006-11-02 Teika Seiyaku Kk 点眼剤
WO2008088612A1 (en) * 2006-12-20 2008-07-24 Bausch & Lomb Incorporated Method of stimulating the production of mucin in the eye of a patient
US7659259B2 (en) * 2006-12-21 2010-02-09 Bausch & Lomb Incorporated Method of treating inflammation of the eye
EP2269612A4 (de) * 2008-04-23 2013-07-31 Otsuka Pharma Co Ltd Augentropfenpräparat und seine verwendung
CA2731271A1 (en) 2008-07-25 2010-01-28 Asahi Kasei Pharma Corporation Stable aqueous solution composition containing sulfonamide compound
JP5420877B2 (ja) * 2008-10-07 2014-02-19 テイカ製薬株式会社 眼科用剤
TW201210584A (en) 2010-08-18 2012-03-16 Alcon Res Ltd Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
US20130149394A1 (en) 2010-08-27 2013-06-13 Wakamoto Pharmaceutical Co., Ltd. Aqueous ophthalmic composition
CN115444849A (zh) * 2016-08-23 2022-12-09 大塚制药株式会社 具有改善的防腐效力或光稳定性的眼科药物组合物
JP6963651B2 (ja) 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
WO1995005803A1 (en) * 1993-08-20 1995-03-02 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
SE9603480L (sv) * 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel

Also Published As

Publication number Publication date
DE69917245T2 (de) 2004-10-21
FR2777189B1 (fr) 2001-04-06
FR2777189A1 (fr) 1999-10-15
KR20010042512A (ko) 2001-05-25
DE69917245D1 (de) 2004-06-17
DK1067966T3 (da) 2004-06-07
AU2842199A (en) 1999-11-01
JP2002511430A (ja) 2002-04-16
CN1139403C (zh) 2004-02-25
JP3725783B2 (ja) 2005-12-14
WO1999052559A1 (fr) 1999-10-21
ES2221740T3 (es) 2005-01-01
CA2324887A1 (fr) 1999-10-21
PT1067966E (pt) 2004-08-31
CA2324887C (fr) 2007-08-07
KR100397622B1 (ko) 2003-09-13
EP1067966B1 (de) 2004-05-12
CN1297359A (zh) 2001-05-30
EP1067966A1 (de) 2001-01-17
US6399605B1 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
ATE266423T1 (de) Betablocker enthaltende ophtalmische zusammensetzungen
HUP9802456A2 (hu) Biológiailag lebontható textillágyító készítmények javított parfüm tartóssággal
CA2411373A1 (en) Stable liquid enzyme compositions with enhanced activity
FI933224A (fi) Detergentkompositioner innehaollande lipas och vattenloesliga kvaternariska ammoniumfoereningar
DK0823940T3 (da) Vandige detergentsammensætninger, der indeholder chelateringsmidler, der forbliver uopløste under sure betingelser
DK1000137T3 (da) Glucanase-holdigt vaskemiddel
ATE135737T1 (de) Festes, hochcheliertes reinigungsmittel
ATE329000T1 (de) Verbesserungen bei flüssigen waschmitteln
ES2054725T3 (es) Heteroaromatos anulares de cinco miembros de p-fenoxi-fenoximetilo.
TR199801877T2 (xx) Kumaş yumuşatıcı eldesi için konsantre, dengeli ön-karışım.
IT1247945B (it) Agente avente attivita' batteriostatica e battericida
AR018969A1 (es) Composiciones blanqueadoras
ATE461276T1 (de) Enzymstabilisierung
DE50002744D1 (de) Verfahren zur herstellung von wässrig-alkalischen lösungen reduzierter indigoider farbstoffe
IT8448935A0 (it) Perfezionamento nelle composizioni acquose contenenti enzimi stabilizzati,in particolare composizioni detergenti
ES2051011T3 (es) Procedimiento de deslavado heterogeneo de articulos a base de algodon teñido.
ATE295352T1 (de) Phenanthridine-n-oxide mit pde-iv hemmender wirkung
DE60208777D1 (de) Flüssigwaschmittel mit verbesserter alpha-amylase-enzymstabilität
DE50013786D1 (de) Polyurethanharnstofffasern mit erhöhter festigkeit
ES2151538T3 (es) Composiciones de limpieza acidas.
NO20001460D0 (no) Alkoholatholdig rengjøringsmiddel
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
PT1086074E (pt) Novo processo
ES2089170T3 (es) Microbicidas.
ES2040338T3 (es) Compuestos antitumorales y antiviricos de origen marino.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1067966

Country of ref document: EP